⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FHTX News
Foghorn Therapeutics Inc. Common Stock
Fesarius Therapeutics demonstrates the science that establishes DermiSphere™ hDRT in a class of its own
prnewswire.com
FHTX
Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
globenewswire.com
FHTX
Form 8-K
sec.gov
FHTX
Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
globenewswire.com
FHTX
Zoom Room Appoints Jackie Mendes as Senior VP of Franchise Development
prnewswire.com
FHTX
Flagship Pioneering Appoints Eric Topol as Academic Advisor to Advance Preemptive Health and Medicine Initiative
prnewswire.com
FHTX
IGC
SANA
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
globenewswire.com
FHTX
Form 8-K
sec.gov
FHTX
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
globenewswire.com
FHTX
Form 8-K
sec.gov
FHTX